MedPath

Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation

Phase 4
Conditions
Bowel Preparation Scale
Adenoma Detection Rate
Registration Number
NCT02832869
Lead Sponsor
Changhai Hospital
Brief Summary

High quality bowel preparation is essential for successful colonoscopy. This study aimed to assess the impact of reinforced education by Wechat or short message service (SMS) on the quality of bowel preparation. This prospective, endoscopist-blinded, randomized, controlled study was conducted. Reinforced education groups received additional education via reminders by Wechat or SMS 2 days before colonoscopy. The primary outcome was the quality of the bowel preparation according to the Boston Bowel Preparation Scale (BBPS). The secondary outcomes included polyp detection rate (PDR), adenoma detection rate (ADR), tolerance, and subjective feelings of patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
450
Inclusion Criteria
  • aged 18-80 years
  • can access to Wechat themselves or through close family members living in the same household
Exclusion Criteria
  • inpatients
  • pregnancy
  • breast feeding
  • history of colorectal surgery
  • patients allergic to PEG-ELS based laxatives

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quality of bowel preparation using Boston Bowel Preparation Scale1 day

The primary outcomes will be the endoscopist's assessment of the quality of preparation using Boston Bowel Preparation Scale

Secondary Outcome Measures
NameTimeMethod
polyp detection rate1 day

The number of polyp prescribed by endoscopist

Patient compliance using a pre-procedure questionnaire1 day

Patient compliance with preparation instructions self-reported in a pre-procedure questionnaire

Trial Locations

Locations (1)

Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

Changhai Hospital
🇨🇳Shanghai, Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.